{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:47:10Z","timestamp":1787010430105,"version":"build-2736575974"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by mutations in the \u03b1-galactosidase A gene that obliterate or markedly reduce \u03b1-galactosidase A activity. This results in the systemic accumulation of its glycosphingolipid substrates in body fluids and organs, including the kidney. Fabry nephropathy can lead to end-stage renal disease requiring kidney transplantation. Little is known about its long-term outcomes and the overall patient survival after kidney transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here, we report 17 Fabry patients (15 male and 2 female subjects) who received kidney transplants and their long-term treatment and follow-up at 4 specialized Fabry centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The posttransplant follow-up ranged to 25 years, with a median of 11.5 (range, 0.8-25.5] years. Graft survival was similar, and death-censored graft survival was superior to matched controls. Fabry patients died with functioning kidneys, mostly from cardiac causes. In 2 male subjects 14 and 23 years posttransplant, the grafts had a few typical FD lamellar inclusions, presumably originating from invading host macrophages and vascular endothelial cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We conclude that kidney transplantation has an excellent long-term outcome in FD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000002252","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T13:18:12Z","timestamp":1524575892000},"page":"1924-1933","source":"Crossref","is-referenced-by-count":18,"title":["Long-term Outcomes of Kidney Transplantation in Fabry Disease"],"prefix":"10.1097","volume":"102","author":[{"given":"Sara","family":"Ers\u00f6zl\u00fc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Desnick","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uyen","family":"Huynh-Do","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Inselspital, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Canaan-K\u00fchl","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Intensive Care Medicine, CVK, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Barbey","sequence":"additional","affiliation":[{"name":"Service of Genetic Medicine, University Hospital Lausanne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Genitsch","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Zurich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Cheetham","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas J.","family":"Flammer","sequence":"additional","affiliation":[{"name":"University Heart Centre, University Hospital Zurich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schaub","sequence":"additional","affiliation":[{"name":"Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","year":"2003","journal-title":"Ann Intern Med"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \"renal variant\" phenotype","volume":"64","year":"2003","journal-title":"Kidney Int"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","article-title":"Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations","volume":"2","year":"2006","journal-title":"Hum Genomics"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2008.02.050","article-title":"Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results","volume":"51","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","year":"2016","journal-title":"Clin Genet"},{"issue":"Suppl 2","key":"bib10-20231002","first-page":"S139","article-title":"Natural history and treatment of renal involvement in Fabry disease","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"bib11-20231002","first-page":"S134","article-title":"Renal pathology in Fabry disease","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.3.5870.28","article-title":"Kidney transplantation in Fabry's disease","volume":"3","year":"1973","journal-title":"Br Med J"},{"issue":"1 Pt 1","key":"bib13-20231002","first-page":"57","article-title":"Ten-year experience in renal transplantation for Fabry's disease","volume":"13","year":"1981","journal-title":"Transplant Proc"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/00007890-200006150-00020","article-title":"Excellent outcome of renal transplantation in patients with Fabry's disease","volume":"69","year":"2000","journal-title":"Transplantation"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1016\/j.transproceed.2005.11.021","article-title":"Kidney transplantation improves survival and is indicated in Fabry's disease","volume":"37","year":"2005","journal-title":"Transplant Proc"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/TP.0b013e318191a842","article-title":"Kidney transplant outcomes in patients with Fabry disease","volume":"87","year":"2009","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"bib17-20231002","first-page":"S144","article-title":"End-stage renal disease in patients with Fabry disease","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1432-2277.2008.00824.x","article-title":"Kidney transplantation in patients with Fabry disease","volume":"22","year":"2009","journal-title":"Transpl Int"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfs526","article-title":"Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice","volume":"28","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJM197212142872402","article-title":"Enzyme replacement therapy by renal allotransplantation in Fabry's disease","volume":"287","year":"1972","journal-title":"N Engl J Med"},{"key":"bib21-20231002","first-page":"247","article-title":"Light- and electron-microscopic histochemistry of Fabry's disease","volume":"103","year":"1981","journal-title":"Am J Pathol"},{"key":"bib22-20231002","first-page":"206","article-title":"Renal biopsy in Fabry's disease eight years after successful renal transplantation","volume":"27","year":"1987","journal-title":"Clin Nephrol"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000464312","article-title":"Disease progression modeling to evaluate the effects of enzyme replacement therapy on kidney function in adult patients with the classic phenotype of Fabry disease","volume":"42","year":"2017","journal-title":"Kidney Blood Press Res"},{"issue":"Suppl 4","key":"bib25-20231002","first-page":"60","article-title":"European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.13 Analysis of patient and graft survival","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"bib26-20231002","first-page":"w14317","article-title":"2222 kidney transplantations at the University Hospital Basel: a story of success and new challenges","volume":"146","year":"2016","journal-title":"Swiss Med Wkly"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","year":"2009","journal-title":"Ann Intern Med"},{"key":"bib28-20231002","first-page":"287","article-title":"Recurrence of Fabry's disease in a renal allograft 14 years after transplantation","volume":"10","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry's disease","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/joim.12077","article-title":"Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications","volume":"274","year":"2013","journal-title":"J Intern Med"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","year":"2007","journal-title":"Ann Intern Med"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2014-102797","article-title":"Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease","volume":"52","year":"2015","journal-title":"J Med Genet"},{"issue":"Suppl 7","key":"bib33-20231002","first-page":"4","article-title":"Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry","volume":"11","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1523-1755.2002.00097.x","article-title":"Patients with Fabry disease on dialysis in the United States","volume":"61","year":"2002","journal-title":"Kidney Int"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/014107688207500716","article-title":"Renal transplantation in Anderson-Fabry disease","volume":"75","year":"1982","journal-title":"J R Soc Med"},{"key":"bib36-20231002","first-page":"1742","article-title":"Fabry's disease. Light and electron microscopic cardiac findings 12 years after successful kidney transplantation","volume":"112","year":"1982","journal-title":"Schweiz Med Wochenschr"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167493","article-title":"Involvement of renal allograft by Fabry's disease","volume":"7","year":"1987","journal-title":"Am J Nephrol"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00007890-199104000-00004","article-title":"Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation","volume":"51","year":"1991","journal-title":"Transplantation"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0041-1345(98)00071-2","article-title":"A case of Fabry's disease with normal kidney function at 10 years after successful renal transplantation","volume":"30","year":"1998","journal-title":"Transplant Proc"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","year":"2001","journal-title":"Exp Biol Med (Maywood)"},{"key":"bib41-20231002","first-page":"91","article-title":"Clinical and biochemical investigation of male patients exhibiting membranous cytoplasmic bodies in biopsied kidney tissues; a pitfall in diagnosis of Fabry disease","volume":"4","year":"2015","journal-title":"J Nephropathol"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/j.ajkd.2006.05.034","article-title":"Iatrogenic phospholipidosis mimicking Fabry disease","volume":"48","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12882-017-0571-0","article-title":"Ultrastructural deposits appearing as \"zebra bodies\" in renal biopsy: Fabry disease? comparative case reports","volume":"18","year":"2017","journal-title":"BMC Nephrol"},{"key":"bib44-20231002","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/modpathol.3800344","article-title":"Chloroquine-induced lipidosis mimicking Fabry disease","volume":"18","year":"2005","journal-title":"Mod Pathol"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/hupa.2003.36","article-title":"Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease: case report and review of the literature","volume":"34","year":"2003","journal-title":"Hum Pathol"},{"key":"bib46-20231002","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/ki.2008.229","article-title":"Progressive renal insufficiency associated with amiodarone-induced phospholipidosis","volume":"74","year":"2008","journal-title":"Kidney Int"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archopht.1981.03930010259007","article-title":"Amiodarone keratopathy: drug-induced lipid storage disease","volume":"99","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"bib48-20231002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ckj\/sft141","article-title":"Renal phospholipidosis possibly induced by ranolazine","volume":"7","year":"2014","journal-title":"Clin Kidney J"},{"key":"bib49-20231002","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.transproceed.2011.06.060","article-title":"Sirolimus-induced pneumonitis complicated by pentamidine-induced phospholipidosis in a renal transplant recipient: a case report","volume":"43","year":"2011","journal-title":"Transplant Proc"},{"key":"bib50-20231002","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.phrs.2011.03.011","article-title":"Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosis","volume":"64","year":"2011","journal-title":"Pharmacol Res"},{"key":"bib51-20231002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000166730","article-title":"Silicon nephropathy mimicking Fabry's disease","volume":"3","year":"1983","journal-title":"Am J Nephrol"},{"key":"bib52-20231002","first-page":"88","article-title":"Fabry disease: correction of the enzymatic deficiency by renal transplantation","volume":"9","year":"1973","journal-title":"Birth Defects Orig Artic Ser"},{"key":"bib53-20231002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0888-7543(91)90493-X","article-title":"Structural organization and complete sequence of the human alpha-N-acetylgalactosaminidase gene: homology with the alpha-galactosidase A gene provides evidence for evolution from a common ancestral gene","volume":"10","year":"1991","journal-title":"Genomics"},{"key":"bib54-20231002","doi-asserted-by":"crossref","first-page":"21859","DOI":"10.1016\/S0021-9258(18)45818-8","article-title":"Human alpha-N-acetylgalactosaminidase-molecular cloning, nucleotide sequence, and expression of a full-length cDNA. Homology with human alpha-galactosidase A suggests evolution from a common ancestral gene","volume":"265","year":"1990","journal-title":"J Biol Chem"},{"key":"bib55-20231002","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0272-6386(12)80172-7","article-title":"Recurrent diseases in the kidney transplant","volume":"24","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"bib56-20231002","first-page":"31","article-title":"Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria","volume":"2","year":"2015","journal-title":"Can J Kidney Health Dis"},{"key":"bib57-20231002","first-page":"3295618","article-title":"FSGS Recurrence in Adults after Renal Transplantation","volume":"2016","year":"2016","journal-title":"Biomed Res Int"},{"key":"bib58-20231002","first-page":"1","article-title":"Female with Fabry Disease Unknowingly Donates Affected Kidney to Sister: A Call for Pre-transplant Genetic Testing","volume":"4","year":"2012","journal-title":"JIMD reports"},{"issue":"Suppl 1","key":"bib59-20231002","first-page":"57","article-title":"Kidney transplantation from a mother with unrecognized Fabry disease to her son with low \u03b1-galactosidase A activity: A 14-year follow-up without enzyme replacement therapy","volume":"21","year":"2016","journal-title":"Nephrology (Carlton)"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201811000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:01:17Z","timestamp":1696208477000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201811000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002252","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}